Finance

Lists
Why is CAMP down 3,03%?
Dive Deeper
CAMP:NASDAQ
CAMP4 Therapeutics Corp
3,84 USD
-3,03%
(-0,12) 1D
3,84 USD
0,00% (0,00)
After hours
Closed: 7-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
3,85 USD
High
4,12 USD
Low
3,84 USD
Mkt. cap
240,97 млн
Avg. vol.
351,01 миң
Volume
148,50 миң
52-wk high
7,75 USD
52-wk low
2,86 USD
EPS
-2,20 USD
Shares outstanding
62,75 млн
No. of employees
48
Open
3,85 USD
High
4,12 USD
Low
3,84 USD
Mkt. cap
240,97 млн
Avg. vol.
351,01 миң
Volume
148,50 миң
52-wk high
7,75 USD
52-wk low
2,86 USD
EPS
-2,20 USD
Shares outstanding
62,75 млн
No. of employees
48
News stories
From web sources and news partners
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
Sector-
Websitecamp4tx.com
Analyst ratings
Based on 5 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current 3,84 USD
15,00 USD (+290,62%)
Average
9,00 USD (+134,38%)
Lowest
6,00 USD (+56,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yun Zhong
Wedbush
Buy
Maintained
8,00 USD
+108,3%
09/29/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
15,00 USD
+290,6%
09/29/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
6,00 USD
+56,3%
09/29/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
09/29/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
7,00 USD
+82,3%
09/28/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
9,00 USD
+134,4%
06/22/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
7,00 USD
+82,3%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
9,00 USD
+134,4%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
795,00 миң
348,00 миң
1,29 млн
1,78 млн
Cost of goods sold
9,36 млн
8,36 млн
10,16 млн
10,82 млн
Cost of revenue
9,36 млн
8,36 млн
10,16 млн
10,82 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 млн
4,77 млн
4,20 млн
4,34 млн
Operating expense
4,60 млн
4,77 млн
4,20 млн
4,34 млн
Total operating expenses
13,95 млн
13,12 млн
14,36 млн
15,16 млн
Operating income
-13,16 млн
-12,78 млн
-13,07 млн
-13,38 млн
Other non operating income
-1,87 млн
-28,22 млн
-6,17 млн
-20,96 млн
EBT including unusual items
-15,10 млн
-40,28 млн
-18,33 млн
-33,53 млн
EBT excluding unusual items
-14,60 млн
-40,28 млн
-18,33 млн
-33,53 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,10 млн
-40,28 млн
-18,33 млн
-33,53 млн
Net profit margin
-1 899,25%
-11 575,86%
-1 416,62%
-1 884,77%
Earnings per share
-0,54
-0,23
-0,21
-0,22
Interest and investment income
423,00 миң
716,00 миң
910,00 миң
807,00 миң
Interest expense
-2,00 миң
-
-
-
Net interest expenses
421,00 миң
716,00 миң
910,00 миң
807,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-12,74 млн
-12,40 млн
-12,55 млн
-12,86 млн
Gain or loss from assets sale
67,00 миң
191,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору